Analyst Ratings for Rein Therapeutics (RNTX)
RNTX Rating Summary
RNTX Price Target Summary
- Highest: $10.00 (H.C. Wainwright)
- Lowest: $10.00 (H.C. Wainwright)
- Average: $10.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.00 (+733.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$10.00 (+733.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/21/2026 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
1.20 (1.20) |
0% | Details |
| 9/22/2025 | H.C. Wainwright » Updated 9/23/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
10.00 (N/A) |
1.21 (1.20) |
-0.83% | Details |
 |
||||||||
|
||||||||
